Research Updates From ASH | Myeloma CAR T-Cell Therapy
https://vimeo.com/1164531982 Myeloma expert and researcher Dr. Ciara Freeman shares key CAR T-cell therapy advances presented at the 2025 American Society of Hematology (ASH) meeting. Dr. Freeman also provides an explanation…
[ACT]IVATED CAR T-Cell Therapy Toolkit Checklist III
Download Checklist Download Checklist See More from [ACT]IVATED CAR T-Cell Therapy
[ACT]IVATED CAR T-Cell Therapy Resource Guide IV
Download Resource Guide Download Resource Guide See More from [ACT]IVATED CAR T-Cell Therapy
复发后的骨髓瘤：新研究对患者的意义
https://vimeo.com/1160266766 德克萨斯大学MD安德森癌症中心的Krina K. Patel医学博士讨论了MAJESTIC-3临床试验中令人鼓舞的新数据，该研究针对首次复发后的多发性骨髓瘤患者，评估了两种免疫疗法联合使用的效果。她解释了这种治疗方法的工作原理、为何研究结果如此令人振奋，以及为何支持性治疗对于安全管理治疗至关重要。Patel医生还分享了实用见解，帮助患者理解这一治疗选择在其整体治疗路径中的潜在定位，在带来希望的同时，强调经过深思熟虑的个体化决策的重要性。 See More from [ACT]IVATED Multiple Myeloma Related Resources What Are Myeloma Risk Factors for Veterans and First Responders? How AI Is Shaping the Future of CAR…
Mieloma Después de la Recaída: Lo Que la Nueva Investigación Significa para los Pacientes
https://vimeo.com/1160265495 La Dra. Krina K. Patel del Centro de Cáncer MD Anderson de la Universidad de Texas analiza datos alentadores del ensayo clínico MAJESTIC-3, que estudió una combinación de dos…
Myeloma After Relapse: What New Research Means for Patients
https://vimeo.com/1160264387 Dr. Krina K. Patel of The University of MD Anderson Cancer Center discusses encouraging new data from the MAJESTIC-3 clinical trial, which studied a combination of two immunotherapies for…
ELEVATE | From Research to Recovery: CAR T-Cell Therapy for Myeloma Patients
https://vimeo.com/1159341084 Dr. Ciara Freeman, a myeloma specialist at Moffitt Cancer Center, discusses recent advances in myeloma CAR T-cell therapy from the 2025 American Society of Hematology (ASH) annual meeting and…
How AI Is Shaping the Future of CAR T and Myeloma Care
https://vimeo.com/1158519733 Exploring the intersection of artificial intelligence and next-generation cancer therapies, Lisa Hatfield, who brings the perspective of living with multiple myeloma, speaks with Dr. Krina K. Patel of The…
Staying [ACT]IVATED Ahead of Relapse: Improving CAR T Durability in Myeloma
https://vimeo.com/1158519769 In a forward-looking discussion on the future of CAR T-cell therapy, Lisa Hatfield, who brings the perspective of living with multiple myeloma, speaks with Dr. Krina K. Patel of…
Getting to CAR T: How Patients Can Overcome Access Barriers
https://vimeo.com/1158519876 Exploring the real-world barriers that can delay access to CAR T-cell therapy, Lisa Hatfield, speaks with Dr. Krina K. Patel of The University of Texas MD Anderson Cancer Center…
Coordinating Care After CAR T: Staying Safe and Connected
https://vimeo.com/1158519831 Lisa Hatfield, PEN’s Myeloma Empowerment Lead, speaks with Dr. Krina K. Patel of The University of Texas MD Anderson Cancer Center about best practices for coordinating care after CAR…
Bridging Therapy & Lymphodepletion: What to Expect on the CAR T Timeline
https://vimeo.com/1158519915 Lisa Hatfield, PEN’s Empowerment Lead who is living with multiple myeloma, speaks with Dr. Krina K. Patel of The University of Texas MD Anderson Cancer Center about key treatment…